Send to a Friend Font Size: Increase Decrease

William Ackman

William Ackman's Portfolio

Ticker	# of Shares	Price	Value
	15,095,528	$195.32	$2,948,458,529
GOOG	9,377,195	$298.30	$2,797,217,269
HLT	9,332,853	$298.64	$2,787,163,220
LOW	7,468,850	$251.89	$1,881,328,627
QSR	23,348,135	$73.98	$1,727,295,028
HHC	16,570,228	$78.76	$1,305,071,158
GOOGL	2,185,000	$298.52	$652,266,200
CMG	953,608	$35.37	$33,729,115
View Additional Portfolio Information »

Bill Ackman runs hedge fund Pershing Square Capital, which he started in 2003 following the dissolution of Gotham Partners.

Ackman is a value investor with an activist bent. Activist investors agitate management for changes. He owns large positions in Target (NYSE: TGT) and Borders (NYSE: BGP). He has also been involved in activist situations at Wendy's (NYSE: WEN) and McDonald's (NYSE: MCD).

Ackman proved his acumen as a short seller in 2007/2008 as short positions he held in MBIA (NYSE: MBI) and Ambac (NYSE: ABK) proved to be big winners due to the credit crunch.

In July 2008, Ackman said he was short the common stock of Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE). Ackman also laid out a plan to reorganize the GSEs, which would wipe out the common shareholders.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Mar 11, 2016 06:19PM Valeant under pressure to beef up management as new board meets
Mar 10, 2016 02:30PM Hedge funds score tiny gains in February - HFR data
Mar 9, 2016 08:52AM Valeant gives Pershing Square 1 board seat, adds 2 other directors
Mar 9, 2016 08:11AM Valeant gives Pershing Square a seat on its board
Mar 8, 2016 05:32PM After-Hours Stock Movers 03/08: (BUFF) (CISG) (AVAV) Higher; (STEM) (PLNT) (ZAGG) Lower (more...)
Mar 8, 2016 05:01PM Valeant to appoint three new directors as soon as Wednesday: sources
Mar 8, 2016 04:43PM Valeant Pharma (VRX) Said in Talks to Add New Director; May Come from Ackman's Pershing Square
Mar 7, 2016 05:06PM Hedge funds score tiny gains in February: HFR data
Mar 4, 2016 07:00AM WPP 2015 Preliminary Results
Mar 2, 2016 09:32AM Ackman's Pershing Square Down 19.9% YTD in 2016
Mar 1, 2016 06:38PM Ackman's Pershing Square Holdings fund down 19.9 percent in 2016
Feb 29, 2016 02:55PM Boys & Girls Harbor Ninth Annual Harbor Investment Conference to Feature Ideas and Insights of Industry-Leading Investment Managers
Feb 25, 2016 06:15PM Herbalife says it is in talks with FTC; outcome uncertain
Feb 24, 2016 04:50PM Ackman's fund off 17.3 percent for year, erases banner gains from 2014
Feb 12, 2016 07:48PM Loeb says Third Point raised short bets to avoid losses
Feb 12, 2016 01:20PM Oxford Saïd receives new funding for the 1+1 MBA scholarships from the Pershing Square Foundation
Feb 10, 2016 07:12PM Ackman's Pershing Square Holdings down 18.6 percent so far in 2016: investor
Feb 5, 2016 03:12PM Hedge funds post worst start to year since 2008: HFR
Feb 3, 2016 02:11PM 'No Blatant Lies' Seen from Valeant (VRX) CEO/CFO Exchange and Philidor Scripts Were Not Just Smoke and Mirrors - Evercore ISI
Jan 31, 2016 03:34PM Ackman, Herbalife unscathed by probes: WSJ
Jan 27, 2016 05:07PM Ackman's Pershing Square Holdings down 11.2 percent so far in 2016
Jan 26, 2016 07:23PM Ackman acknowledges mistakes in 2015, details changes in portfolio
Jan 26, 2016 10:38AM Portfolios With Purpose Chooses Lumentus as Social Media Agency Of Record
Jan 25, 2016 11:19AM Bernstein Sees Multiple Ways to Win in Mondelez (MDLZ); End-Game Points to M&A
Jan 20, 2016 04:11PM U.S. hedge funds boast lower losses as markets tumble further
Jan 19, 2016 07:06AM Caution, teamwork trumped bravado for some hedge funds in 2015
Jan 6, 2016 09:27AM Pershing Square's Ackman Thinks Interim Valeant (VRX) CEO Schiller Will Do 'Outstanding Job'
Jan 6, 2016 08:43AM Valeant names interim CEO; timing of Pearson's return unknown
Jan 5, 2016 10:53AM Valeant Pharma (VRX) Sees Sharp Upside
Jan 5, 2016 08:51AM Ackman's Pershing Square ends 2015 with 20.5 pct drop
Jan 4, 2016 01:31PM Jana Partners hedge fund down 5.4 percent in 2015: investor update
Dec 31, 2015 05:09PM Ackman's fund sells 5 million Valeant shares to generate tax loss
Dec 31, 2015 04:26PM Ackman's Pershing Square Sold Nearly 5M Shares of Valeant Pharma (VRX) for Tax Purposes
Dec 23, 2015 05:28PM Market Wrap: Durable Goods Orders Outpaced in Nov.; Crude Rises on Surpise Inventory Drop; KaloBios Gets Delisting Notice
Dec 23, 2015 04:45PM Ackman's Pershing Square Having an Up Month in December
Dec 16, 2015 08:40AM Valeant says can contain hit to dermatology, projects 2016 growth
Dec 15, 2015 09:17PM Ackman tells investors that this year could be his firm's worst ever
Dec 15, 2015 12:37PM Canadian Pacific Railway (CP) CEO & CFO and Bill Ackman to Host Call on December 16
Dec 15, 2015 12:21PM CP to address financial community on December 16
Dec 15, 2015 09:06AM Valeant Pharma (VRX) CEO Pearson Says Walgreens Deal 'More than Replaces' Philidor
Dec 13, 2015 01:30PM Valeant hires attorney, crisis management firm as U.S. scrutiny mounts
Dec 11, 2015 01:03PM Norfolk Southern (NSC) said to court holders to blunt Bill Ackman's M&A push - Bloomberg
Dec 8, 2015 04:39PM Ackman plays big role in laying out Canadian Pacific rail deal
Dec 8, 2015 07:32AM CP says willing to take Norfolk bid to shareholders
Dec 7, 2015 09:23AM CP (CP) CEO and Bill Ackman to Address Investment Community on Tuesday
Dec 4, 2015 07:01AM Norfolk Southern (NSC) Board Rejects Unsolicited Offer from Canadian Pacific (CP)
Dec 4, 2015 07:00AM Norfolk Southern Board Of Directors Unanimously Rejects Unsolicited Indication Of Interest From Canadian Pacific
Dec 1, 2015 04:24PM Ackman's Pershing Square off 15 percent for the year: source
Dec 1, 2015 01:09AM Exclusive: Fidelity star Danoff grows cautious about unicorn phenomenon
Dec 1, 2015 01:09AM Exclusive: Fidelity star Danoff grows cautious about unicorn phenomenon

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed